Piper Sandler analyst Paul Newsome raised the firm’s price target on Bowhead Specialty (BOW) to $32 from $30 and keeps an Overweight rating on the shares. Discussing the sector, the firm believes fourth quarter results will be generally mixed. Piper expects favorable weather will mean that most insurers should have strong or even stronger-than-expected results, but pricing commentary will likely be more pessimistic. A key sign will be if insurance company managements continue to believe they are getting rate in excess of claims inflation, it adds.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BOW:
- Bowhead Specialty Secures $35M Credit Facility Agreement
- Bowhead Specialty Completes $150M Senior Notes Offering
- Bowhead Specialty resumed with an Outperform at RBC Capital
- Bowhead Specialty price target lowered to $29 from $31 at Morgan Stanley
- Bowhead Specialty’s Q3 2025 Earnings: Strong Growth Amid Challenges
